
Venture capital · Early stage
Illumina Ventures
Illumina Ventures is an independently managed venture firm focused on early-stage genomics and precision health companies, with offices in the San Francisco Bay Area and Dublin and a strategic relationship with Illumina.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Illumina Ventures right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds Illumina Ventures joined, from press and the firm’s own posts.
2 rounds in the last 12 months
Round sizes, Illumina Ventures’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Illumina Ventures backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Illumina Ventures
Events where Illumina Ventures’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Illumina Ventures is based in Foster City, United States. It also has an office in Dublin.
3 fund vehicles are on public registers (SEC adviser filings), including ILLUMINA INNOVATION FUND II, L.P., ILLUMINA INNOVATION FUND I, L.P. and ILLUMINA INNOVATION FUND III, L.P.
Stages: Early stage. Sectors: Life sciences. From the firm’s own website.
The firm backs early-stage companies across life science tools, diagnostics, therapeutics, digital health and sustainability, working as a partner to entrepreneurs turning breakthrough science into market leaders. Its labs offer capital, sequencing, mentorship and genomics lab capabilities. From the firm’s own website.
Illumina Ventures lists 40 portfolio companies on its website, including Actym Therapeutics, Alamar Biosciences, Arbor Biotechnologies, Arima Genomics and Attovia Therapeutics.
Firms whose websites list some of the same companies include ARCH Venture Partners, Deviation Capital and Mission BioCapital.
Know before Illumina Ventures’s next round is announced.
PRO tracks Illumina Ventures’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.